I wish we knew as I've been waiting for the buyout to avoid commission and fees but that seems foolish now with the significant drop in share price. As one article mentioned, this seems like a very stupid move by the regulators since the two businesses do not have competing product lines--the merger is complimentary rather than reducing competition unfairly. I hope management will continue trying to improve the companies profits and other products so if the merger is blocked they can be in a great position earning wise and therefore get back to improving the share price. Many felt that the buyout price was very low compared to where it should have been based on the markets for their medicines.
